If you deal with vaginal infections every now and then consult with a doctor as there are chances that it might impact your ...

LACTIN-V is under clinical development by Osel and currently in Phase I for Cervical Cancer. According to GlobalData, Phase I drugs for Cervical Cancer have an 80% phase transition success rate (PTSR) ...

LACTIN-V is under clinical development by Osel and currently in Phase I for Human Papillomavirus Infections. According to GlobalData, Phase I drugs for Human Papillomavirus Infections have an 87% ...

Of all risk factors explored thus far, the majority of epidemiologic studies have identified sexual behaviour as the primary risk factor to the occurrence of BV. The nature of this association ...

Vaginal candidiasis is a major concern in women's health. There is a plethora of advice available online, with many remedies claiming to offer simple solutions for the prevention and treatment of this ...

There is a significant unmet medical need for an effective, non-antibiotic prophylactic intervention for recurrent urinary tract infections. The sublingual vaccine provides an effective treatment ...

Two Perth patients with advanced melanoma have become the first in Australia to try a new type of cancer treatment. The treatment included standard immunotherapy, followed by surgery, high-dose ...

I spent time in a locked facility and in foster care. “Treatment” felt like punishment, focused on coercing my obedience while ignoring my emotions. What shocked me about Dr. M was that ...

F. nucleatum, an oral anaerobe, is frequently associated with colorectal cancer and is linked to increased cancer cell proliferation, metastasis, and poor treatment outcomes. Recent studies have ...

The rape and murder of a trainee doctor at a hospital has led to widespread outrage across India, reigniting debates over sexual violence against women. The 31-year-old was attacked this month ...

If you live with treatment-resistant insomnia, it means first-line therapies were likely ineffective for treating your condition. Finding relief may require exploring new pharmaceutical options ...

Elastic BV Bearer and Registered Shares will release figures for the most recent quarter on August 29. Wall Street analysts predict earnings per share of $0.253. Go here to follow Elastic BV ...